Categories: News

Exer Adds World-class Surgeons to its Team of Advisors and Announces Apps as FDA Medical Devices

Three of the nation’s top surgeons, representing the Steadman Clinic and Colorado Sports Medicine and Orthopedics, will help take Exer’s assessment and treatment platforms to the next level

DENVER, June 15, 2022 /PRNewswire/ — Exer Labs, an AI-powered digital health company committed to helping healthcare professionals leverage computer vision to modernize their assessments and treatment plans, announced today that Exer’s Physio mobile app is now an FDA Class II medical device, and that the company is welcoming three medical advisors to their team of stakeholders dedicated to revolutionizing the digital health industry. Renowned orthopedic surgeons Dr. Tom Hackett, Dr. Catherine Logan and Dr. Matthew Provencher are joining Exer’s Advisory Board and will contribute their unique expertise in medical assessment, prevention, treatment and recovery to helping the company deliver on its mission to help millions move, train and play better.

Dr. Tom Hackett is an orthopaedic surgeon whose practice at The Steadman Clinic in Vail, Colorado, focuses on the surgical and non-surgical treatment of elbow, shoulder and knee disorders. He is the Head Team Physician for the U.S. Ski and Snowboard Team.

Dr. Catherine Logan, MD, MBA, MSPT, is a sports medicine orthopaedic surgeon specializing in complex knee and shoulder surgery at Colorado Sports Medicine and Orthopaedics (COSMO) located in Denver, Colorado. A team physician for the U.S. Ski and Snowboard Team, Dr. Logan is also the Medical Director and Head League Physician for the Premier Lacrosse League.

Dr. Matthew T. Provencher, MD MC US, is an orthopaedic surgeon who specializes in complex shoulder and knee surgery, as well as sports surgery. In addition to his role at The Steadman Clinic and Steadman Philippon Research Institute in Vail, Colorado, Dr. Provencher is a graduate of the United States Naval Academy, a prolific and accomplished researcher, and the chairman of the Vail Health Institutional Review Board.

“I want to thank Drs. Hackett, Logan and Provencher for their faith in what we’re trying to do at Exer and their willingness to partner with us as we build a digital health company that will change people’s lives,” said Exer Co-Founder and CEO Zaw Thet. “We’ve spent years developing our next-generation technology, working with healthcare payers and providers to align our solutions with their treatment and billing practices, and engaging with government regulators to push the digital health industry forward. Today is another milestone for us and the insights and expertise of these three outrageously smart orthopedic surgeons will ensure that our technology is delivering the sort of outcomes that patients deserve.”

Exer’s Physio application is powered by a custom, next-generation AI and it runs on any device with a 2D camera (phone, tablet, laptops, etc). The software identifies specific joints on the human body which provides physical therapists and their patients with real-time data and summary metrics during exercises and functional movements, enabling high quality care both inside the clinic and remotely.

Backed by top-tier venture capital and angel investors that include Signia Venture Partners, AME Cloud Ventures, Morado Ventures, Oceans Ventures, and Operator Partners, Exer is committed to helping the world move, train and play better.

Additional background information on all three new Exer advisors is available here, here and here.

For more information on Exer’s suite of apps for digital physical therapy, gait analysis and more – and the technology that drives it all – visit https://www.exer.ai.

Press contact: Mark Jones, Agado Communications
                         +1-719-358-3287
                          338483@email4pr.com

Press kit: https://exer.ai/presskit

View original content to download multimedia:https://www.prnewswire.com/news-releases/exer-adds-world-class-surgeons-to-its-team-of-advisors-and-announces-apps-as-fda-medical-devices-301567938.html

SOURCE Exer Labs

Staff

Recent Posts

Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference

SEATTLE, WA / ACCESSWIRE / March 18, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage…

32 mins ago

BioNxt Reports Commercialization of ODF Cladribine Product for MS Next Steps

VANCOUVER, BC / ACCESSWIRE / March 18, 2024 / BioNxt Solutions Inc. ("BioNxt" or the…

32 mins ago

Unique Treatment for BPH, Chronic Prostatitis, Back Pain and Kidney Stones Was Unveiled at Arab Health 2024 by Ariana Adjani

* Efficacy, safety, and cost-effectiveness of Thermobalancing therapy and Dr Allen's Devices were showcased at…

22 hours ago

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

2 days ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

2 days ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

2 days ago